The LIMCR (Laboratory for Immunological and Molecular Cancer Research) was founded in 2005 by Prof. Richard Greil. A particular focus of the LIMCR is leukemia research in the field of chronic lymphocytic leukemia, myelodysplastic syndrome and acute myeloid leukemia.
The special feature of the LIMCR research concept is the direct embedding of the research laboratory in clinical practice. The main objectives are, on the one hand, to link research on tumor material from cancer patients as closely as possible with clinical observations and, on the other hand, to transfer clinical experience to the laboratory and subsequently use the research results to establish new treatment methods. The knowledge gained from experimental research is to be systematically and rapidly implemented in medical practice in order to be able to offer cancer patients an innovative and individually tailored therapy.
